Australia Biomaterials in Healthcare Market Report 2022 to 2030

Australia Biomaterials in Healthcare Market Analysis

$ 3999

Australia Biomaterials Healthcare Market is expected to witness growth from $1.87 Bn in 2022 to $5.61 Bn in 2030 with a CAGR of 14.70% for the forecasted year 2022-30. The demand for biomaterials in Australia is being driven by the rising prevalence of diseases like periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, which is anticipated to spur development in the country's biomaterial healthcare market. The market is segmented by type and by application. Some key players in this market include Anatomics, PolyNovo, OPED Australia, BASF SE, Johnson and Johnson, Medtronic, and Evonik Industries.

ID: IN10AUMD003 CATEGORY: Medical Devices GEOGRAPHY: Australia AUTHOR: Jigyasu Bhandari

Buy Now

Australia Biomaterials in Healthcare Market Executive Analysis

Australia Biomaterials Healthcare Market size is at around $1.87 Bn in 2022 and is projected to reach $5.61 Bn in 2030, exhibiting a CAGR of 14.70% during the forecast period. The estimated overall health spending in Australia for 2022–2023 is $105.8 billion. In Australia, health spending currently accounts for 10.7% of the GDP. About 17% of all health spending in Australia is covered solely by individual consumers. $29.8 billion, or about $1,235 per individual, is total.

Substances used in implants, medical devices, and medication delivery methods are known as biomaterials. They can be used to replace or repair damaged tissues or organs because they are made to communicate with biological systems. Biomaterials are used in a variety of healthcare uses in India. In orthopaedic procedures, biomaterials are used to replace or repair broken bones and joints. They can be used to make fixation pins, bone grafts, and artificial joints. These substances are safe, which means that they have no negative effects on the body. Additionally, they can be developed to have the same mechanical characteristics as real bone, which makes them perfect for use in orthopaedic use. Additionally, cardiovascular uses use biomaterials. They can be used to make cardiac valves, stents, and other implantable medical devices. These materials can endure challenging conditions inside the body because they are biocompatible.

Australia Biomaterials Healthcare Market Analysis

Market Dynamics

Market Growth Drivers

The demand for biomaterials in Australia is being driven by the rising prevalence of diseases like periodontal disease, tooth decay, oral cancer, halitosis, and dental caries, which is anticipated to spur development in the country's biomaterial healthcare market. Biomaterials include metals, polymers, ceramics, and composites. The advantages of biomaterials in healthcare are becoming more widely known among patients and healthcare workers. Demand is probably going to keep rising as more people become familiar with these things. The demand for biomaterials to address age-related illnesses like osteoarthritis, spinal problems, and cardiovascular disease is rising in Australia as the population gets older. The Australian government is devoted to fostering the biomaterials market's expansion. This includes financial support for research and development, tax breaks, and regulatory assistance, all of which contribute to the development and growth of the Australian biomaterial healthcare market.

Market Restraints

In Australia's highly competitive biomaterials industry, many businesses are striving for market share. This could lead to price volatility, which would lower the profitability of production companies. It may be difficult for new biomaterials businesses in Australia to break into the healthcare biomaterials market due to the high cost of manufacturing biomaterials. The use of biomaterials in certain circumstances, such as stem cell research and tissue engineering, may be constrained by ethical concerns.

Competitive Landscape

Key Players

Anatomics (AU)
PolyNovo (AU)
OPED Australia (AU)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Notable Recent Deals

2021: A distribution agreement with Corza Medical was revealed by PolyNovo, an Australian business that creates and produces bioresorbable polymers for medical use. In accordance with the contract, Corza Medical will be responsible for the American distribution of PolyNovo's NovoSorb BTM product range.

Healthcare Policies and Regulatory Landscape

The regulatory body in charge of regulating biomaterials, in Australia, is known as the Therapeutic Goods Administration (TGA). Before marketing and selling their goods in Australia, manufacturers must have TGA approval. Manufacturers must submit extensive information about their products to receive approval from the TGA, which has stringent standards for safety and efficacy. All therapeutic products that have been authorised for use in Australia, including biomaterials, are listed in the Australian Register of Therapeutic Goods (ARTG), a directory that is accessible to the general public. Access to information about approved products, their indications, dosages, and adverse effects is made possible by this database for patients and healthcare workers. The National Health and Medical Research Council (NHMRC) is in charge of creating policies and benchmarks for moral behaviour in biomaterials-related medical studies. The goals of the NHMRC's guidelines are to guarantee that research is carried out ethically, transparently, and with the proper level of participant-informed agreement.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Australia market in 2019. The growing geriatric population Australialy is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.